As of Feb 20, 2025, Acadia Healthcare Company, Inc. Intrinsic Value is $43.0. This suggests it may be undervalued by 5.4% compared to its current price of around $40.8.
As of Feb 20, 2025, Acadia Healthcare Company, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $40.8, using a discount rate of 7.3% and terminal growth rate of 3.0%.
Acadia Healthcare Company, Inc. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $43.0, compared to a market price of around $40.8. This suggests a potential undervaluation of 5.4%.